Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marius König"'
Autor:
Simon Woelfel, Joel Dütschler, Daniel Junker, Marius König, Georg Leinenkugel, Nicole Graf, Claudia Krieger, Samuel Truniger, Annett Franke, Seraina Koller, Katline Metzger-Peter, Melanie Oberholzer, Nicola Frei, Nora Geissler, Peter Schaub, STAR SIGN Investigators, Werner C. Albrich, Matthias Friedrich, Jan Hendrik Niess, Nicole Schneiderhan-Marra, Alex Dulovic, Wolfgang Korte, Justus J. Bürgi, Stephan Brand
Publikováno v:
Vaccines, Vol 12, Iss 7, p 774 (2024)
Recently updated COVID-19 mRNA vaccines encode the spike protein of the omicron subvariant XBB.1.5 and are recommended for patients with inflammatory bowel disease (IBD) on immunosuppressive treatment. Nonetheless, their immunogenicity in patients wi
Externí odkaz:
https://doaj.org/article/2fdeebad3bb644b1a2cf47e2eefe19a1
Autor:
Micha T. Maeder, Tabea König, Sanja Bogdanovic, Irene Schneider, Werner Eugster, Peter Ammann, Marius König, Jürg H. Beer, Hans Rickli
Publikováno v:
Swiss Medical Weekly, Vol 147, Iss 3940 (2017)
AIM OF THE STUDY: To better appreciate the role of the non-vitamin K oral anticoagulants (NOACs) for patients with non-valvular atrial fibrillation in Switzerland we aimed to assess the quality of vitamin K antagonist (VKA) anticoagulation in daily p
Externí odkaz:
https://doaj.org/article/894d3d31d36640fdbb7a8fe91a1c0e4b
Autor:
Marius König, Tabea König, Irene Schneider, Peter Ammann, Micha T. Maeder, Jürg H. Beer, Hans Rickli, Werner Eugster, Sanja Bogdanovic
Publikováno v:
Swiss medical weekly. 147
AIM OF THE STUDY To better appreciate the role of the non-vitamin K oral anticoagulants (NOACs) for patients with non-valvular atrial fibrillation in Switzerland we aimed to assess the quality of vitamin K antagonist (VKA) anticoagulation in daily pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fc99c281580b2408a6dda9e035eee62
https://pubmed.ncbi.nlm.nih.gov/29039622
https://pubmed.ncbi.nlm.nih.gov/29039622